MeiraGTx Holdings (MGTX) Interest Expenses (2017 - 2025)
MeiraGTx Holdings (MGTX) reported Interest Expenses of $3.1 million for Q4 2025, down 10.44% on a YoY basis from $3.4 million in Q4 2024, and little changed quarter-over-quarter from $3.1 million in Q3 2025.
MeiraGTx Holdings (MGTX) Interest Expenses (2017 - 2025) Analysis & Trends
MeiraGTx Holdings has reported Interest Expenses for 9 years, with the latest figure at $3.1 million in Q4 2025.
- For the quarter ending Q4 2025, Interest Expenses fell 10.44% year-over-year to $3.1 million; the trailing twelve-month figure through Dec 2025 stood at $12.2 million (down 8.1% YoY), and the FY2025 full-year result was $12.2 million, down 8.1% from the prior year.
- Interest Expenses for Q4 2025 stood at $3.1 million, roughly flat from $3.1 million in the prior quarter.
- The five-year high for Interest Expenses was $3.4 million in Q4 2023, with the low at $51000.0 in Q2 2021.
- Historically, Interest Expenses has averaged $2.2 million across 5 years, with a median of $3.0 million in 2025.
- Annual changes were most pronounced in 2023 — Interest Expenses jumped 3991.46% — and 2025, when it decreased 10.44%.
- MeiraGTx Holdings' Interest Expenses stood at $119000.0 in 2021, then soared by 2332.77% to $2.9 million in 2022, then increased by 19.14% to $3.4 million in 2023, then fell by 1.1% to $3.4 million in 2024, then decreased by 10.44% to $3.1 million in 2025.
- The last three Interest Expenses figures came in at $3.1 million (Q4 2025), $3.1 million (Q3 2025), and $3.0 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int Expense (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -5.50 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -332,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 61,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -2,753.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -5.58 Mn |
| 10 | MeiraGTx Holdings | 910.47 Mn | 844.54 Mn | 74.89 Mn | 3.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.06 Mn |
| Dec 31, 2025 | 3.06 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.07 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Jun 30, 2025 | 3.03 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Mar 31, 2025 | 3.04 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Dec 31, 2024 | 3.41 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Sep 30, 2024 | 3.36 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Jun 30, 2024 | 3.25 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Mar 31, 2024 | 3.25 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Dec 31, 2023 | 3.45 Mn |
| Sep 30, 2023 | 3.38 Mn |
| Sep 30, 2023 | 3.38 Mn |